Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-004899
Filing Date
2025-11-13
Accepted
2025-11-13 09:16:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11291
2 JOINT FILING AGREEMENT p25-2391exhibit991.htm EX-99.1 3660
  Complete submission text file 0000902664-25-004899.txt   16972
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Subject) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-60487 | Film No.: 251475779
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 617-867-2800
Adage Capital Management, L.P. (Filed by) CIK: 0001535978 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G